EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Non-femoral focused transaxillary access in TAVI: GARY data analysis and future trends

Max M Meertens, Matti Adam, Andreas Beckmann, Stephan Ensminger, Christian Frerker, Moritz Seiffert, Jan-Malte Sinning, Raffi Bekeredjian, Thomas Walther, Friedhelm Beyersdorf, Helge Möllmann, Ümniye Balaban und 3 weitere

Clinical Research in Cardiology · 2025

DOI: 10.1007/s00392-024-02402-9 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Clinical Research in Cardiology, 2025. Verfasst von Max M Meertens und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department III of Internal Medicine, University Hospital of Cologne, Cologne, Germany. max.meertens@me.com. Hauptthemen laut MEDLINE: Transcatheter Aortic Valve Replacement, Registries, Aortic Valve Stenosis, Aortic Valve. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsches Zentrum fuer Herz-Kreislauf Forschung, Universitätsklinikum Köln.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In patients not suitable for transfemoral transcatheter aortic valve implantation (TAVI), several access strategies can be chosen.

Aim

To evaluate the use and patient outcomes of transaxillary (TAx), transapical (TA), and transaortic (TAo) as alternative access for TAVI in Germany; to further evaluate surgical cutdown vs. percutaneous TAx access.

Methods

All patients entered the German Aortic Valve Registry (GARY) between 2011 and 2019 who underwent non-transfemoral TAVI were included in this analysis. Patients with TA, TAo, or TAx TAVI were compared using a weighted propensity score model. Furthermore, a subgroup analysis was performed for TAx regarding the percutaneous or surgical cutdown approach.

Results

Overall, 9686 patients received a non-transfemoral access. A total of 8918 patients (92.1%) underwent TA, 398 (4.1%) TAo, and 370 (3.8%) TAx approaches. Within the TAx subgroup, 141 patients (38.1%) received subclavian cutdown, while 200 (54.1%) underwent a percutaneous approach. The TA patients had a significantly lower 30-day survival than TAx patients (TA 90.92% vs. TAx 95.59%, p = 0.006; TAo 92.22% vs. TAx 95.59%, p = 0.102). Comparing percutaneous and cutdown TAx approaches, no significant differences were seen. However, more vascular complications occurred (TA 1.8%, TAo 2.4%, TAx 12.2%; p < .001), and the hospital length of stay was shorter (TA 12.9 days, TAo 14.1 days, TAx 12 days; p < .001) after TAx access.

Conclusion

It may be reasonable to consider TAx access first in patients not suitable for TF-TAVI, because the 30-day survival was higher compared with TA access and the 1-year survival was higher compared with TAo access. It remains important for the heart teams to offer alternative access modalities for patients not amenable to the standard TF-TAVI approaches. Graphical Abstract

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transcatheter Aortic Valve ReplacementRegistriesAortic Valve StenosisAortic ValveHumansMaleFemaleGermanyAged, 80 and overAgedAxillary ArteryTreatment OutcomeRetrospective StudiesFemoral ArterySurvival RatePropensity Score

Stichwörter der Autor:innen

GARYTAVITransaorticTransapicalTransaxillaryTransfemoralTranssubclavian

Autor:innen und Institutionen

  • Department III of Internal Medicine, University Hospital of Cologne, Cologne, Germany. max.meertens@me.com.
  • Department III of Internal Medicine, University Hospital of Cologne, Cologne, Germany.
  • Department of Cardiac and Pediatric Cardiac Surgery, Evanglish Clinical Center Niederrhein, Heart Center Duisburg, Duisburg, Germany.
  • Department of Cardiac and Thoracic Vascular Surgery, University Heart Center Lübeck, University Hospital of Schleswig Holstein, Lübeck, Germany.
  • German Center for Cardiovascular Research (DZHK), Partner Sie Hamburg-Kiel-Lübeck, Berlin, Germany.
  • Department of Cardiology, Angiology and Intensive Care Medicine, University Heart Center Lübeck, University Hospital Schleswig-Holstein, Lübeck, Germany.

Förderung

  • Deutsches Zentrum fuer Herz-Kreislauf Forschung
  • Universitätsklinikum Köln

Zitieren

APA

Meertens, M. M., Adam, M., Beckmann, A., Ensminger, S., Frerker, C., Seiffert, M., Sinning, J. M., Bekeredjian, R., Walther, T., Beyersdorf, F., Möllmann, H., Balaban, Ü., Eghbalzadeh, K., Rudolph, T. K., & Bleiziffer, S. (2025). Non-femoral focused transaxillary access in TAVI: GARY data analysis and future trends. Clinical Research in Cardiology. https://doi.org/10.1007/s00392-024-02402-9

Vancouver

Meertens MM, Adam M, Beckmann A, Ensminger S, Frerker C, Seiffert M, et al. Non-femoral focused transaxillary access in TAVI: GARY data analysis and future trends. Clinical Research in Cardiology. 2025. doi:10.1007/s00392-024-02402-9

BibTeX
@article{Meertens2025,
  author = {Meertens, Max M and Adam, Matti and Beckmann, Andreas and Ensminger, Stephan and Frerker, Christian and Seiffert, Moritz and Sinning, Jan-Malte and Bekeredjian, Raffi and Walther, Thomas and Beyersdorf, Friedhelm and Möllmann, Helge and Balaban, Ümniye and Eghbalzadeh, Kaveh and Rudolph, Tanja K and Bleiziffer, Sabine},
  title = {Non-femoral focused transaxillary access in TAVI: GARY data analysis and future trends},
  journal = {Clinical Research in Cardiology},
  year = {2025},
  doi = {10.1007/s00392-024-02402-9}
}
Kostenlos starten →